Haematological biomarkers of pathological response on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA non-small cell lung cancer (NSCLC) patients.

被引：0
|
作者：
Laza Briviesca, Raquel
Cruz Bermudez, Alberto
Barquin, Miguel
Nadal, Ernest
Insa, Amelia
Garcia-Campelo, Rosario
De Dios Alvarez, Noemi
Domine, Manuel
Massuti, Bartomeu
Majem, Margarita
Rodriguez-Abreu, Delvys
Martinez Marti, Alex
Cobo, Manuel
Lopez-Vivanco, Guillermo
del Barco, Elvira
Bernabe, Reyes
Vinolas, Nuria
Barneto, Isidoro
Viteri, Santiago
Provencio-Pulla, Mariano
机构：
[1] Hosp Univ Puerta De Hierro Majadahonda, Inst Invest Sanitaria Puerta De Hierro Segovia Ar, Madrid, Sudan
[2] Hosp Univ Puerta de Hierro, Majadahonda, Spain
[3] Inst Catala Oncol, Barcelona, Spain
[4] Hosp Clin Univ Valencia, Valencia, Spain
[5] Univ Hosp A Coruna, Coruna, Spain
[6] Complejo Hosp Univ Vigo, Vigo, Spain
[7] Univ Hosp Fdn Jimenez Diaz, Dept Oncol, Madrid, Spain
[8] Univ Hosp Fdn Jimenez Diaz, Translat Oncol Div, Madrid, Spain
[9] Alicante Univ Hosp ISABIAL, Alicante, Spain
[10] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[11] Hosp Univ Insular Gran Canaria, Las Palmas Gran Canaria, Spain
[12] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Barcelona, Spain
[13] Hosp Reg Univ Malaga, Malaga, Spain
[14] Hosp Cruces, Dept Med Oncol, Baracaldo, Spain
[15] Salamanca Univ Hosp, Dept Med Oncol, Salamanca, Spain
[16] Hosp Valme, Seville, Spain
[17] Hosp Clin Barcelona, Barcelona, Spain
[18] Hosp Reina Sofia, Cordoba, Spain
[19] Pangaea Biotech, Clin Unit, Barcelona, Spain
[20] Hosp Univ Puerta de Hierro, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20026
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Adjuvant treatment for resectable non-small cell lung cancer
    Lim, Jeong Uk
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2023, 66 (03): : 173 - 179
  • [32] Pathologic response as a surrogate endpoint for event-free survival in neo-adjuvant immunotherapy trials of resectable non-small cell lung cancer: A subgroup analysis
    Huang, N.
    Shivasabesan, G.
    Lord, S.
    Lee, C. K.
    Kok, P. S.
    ANNALS OF ONCOLOGY, 2024, 35 : S791 - S792
  • [33] The Role of Neoadjuvant Chemo-Immunotherapy in Unresectable Non-Small Cell Lung Cancer
    Oh, M.
    Davis, A.
    Lentz, R.
    Peterman, N.
    Robertson, A.
    Srivas, R.
    Lambert, N.
    Wilson, T.
    Tezcan, H.
    Bharat, A.
    Chae, Y. K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S947 - S948
  • [34] Biomarkers of response to immunotherapy in early stage non-small cell lung cancer
    Dugage, Matthieu Roulleaux
    Albarran-Artahona, Victor
    Laguna, Juan Carlos
    Chaput, Nathalie
    Vignot, Stephane
    Besse, Benjamin
    Mezquita, Laura
    Auclin, Edouard
    EUROPEAN JOURNAL OF CANCER, 2023, 184 : 179 - 196
  • [35] The expanding role of systemic treatment in non-small cell lung cancer neo-adjuvant therapy
    Felip, E.
    Vilar, E.
    ANNALS OF ONCOLOGY, 2006, 17 : X108 - X112
  • [36] Neo-adjuvant chemotherapy in early stages of non-small cell lung cancer
    Crinò, L
    LUNG CANCER, 2002, 38 : S31 - S32
  • [37] Different pathological response and histological features following neoadjuvant chemotherapy or chemo-immunotherapy in resected non-small cell lung cancer
    Ali, Greta
    Poma, Anello Marcello
    Di Stefano, Iose
    Zirafa, Carmelina Cristina
    Lenzini, Alessandra
    Martinelli, Giulia
    Romano, Gaetano
    Chella, Antonio
    Baldini, Editta
    Melfi, Franca
    Fontanini, Gabriella
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [38] Predictive And Prognostic Role Of Metabolic Response In Patients With Non-Small Cell Lung Carcinoma (NSCLC) Treated With Neo-adjuvant Chemotherapy
    Castello, A.
    Toschi, L.
    Rossi, S.
    Finocchiaro, G.
    Grizzi, F.
    Qehajaj, D.
    Lopci, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S171 - S172
  • [39] Evaluation of Treatment Strategies for Patients with Stage IIIA Non-Small Cell Lung Cancer in the Immunotherapy Era
    Alabaster, A.
    Velotta, J. B.
    Tupper, H. I.
    Natanzon, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S584 - S585
  • [40] Immunotherapy alone or chemo-immunotherapy as front-line treatment for advanced non-small cell lung cancer
    Shafique, Michael
    Tanvetyanon, Tawee
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (03) : 225 - 232
12345